Neurodegenerative Disease and Cognitive Assessment
Research activity includes Huntington disease, with attention to early cognitive change, disease progression, and sensitive clinical measures drawn from the Unified Huntington’s Disease Rating Scale.
- Huntington disease
- Cognitive subtests
- Disease progression
- Pre-symptomatic phase
The clinical focus extends to neurological outcomes that help characterize functional decline in inherited movement disorders.
Haematologic Malignancy
The sponsor is involved in studies of acute myeloid leukemia, with interest in treatment response after initial standard therapy and in strategies for patients with persistent disease burden.
- Acute myeloid leukemia
- Venetoclax
- Azacitidine
- Treatment resistance
Its oncology portfolio reflects engagement with blood cancer management and therapeutic intensification in refractory settings.
Gynecologic Oncology
Clinical work also covers ovarian cancer, particularly early-stage disease and the evaluation of nodal involvement in surgical staging.
- Ovarian cancer
- Sentinel lymph node technique
- Pelvic lymphadenectomy
- Aortic lymphadenectomy
This area links gynecologic oncology with surgical decision-making and assessment of metastatic spread.
Clinical Trial Coordination
Based in Valencia, Spain, the sponsor operates as a clinical trial coordinating center with multicentre activity across collaborating research sites in Europe.
- Multicentre clinical research
- Recruiting studies
- Cross-border collaboration
- Research site coordination
Its trial portfolio spans neurology, haematology, and oncology domains.
